Seitz P K, Thomas M L, Cooper C W
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.
J Bone Miner Res. 1986 Feb;1(1):51-6. doi: 10.1002/jbmr.5650010109.
Binding of calcitonin (CT) and calcitonin gene-related peptide (CGRP) to rat hemicalvariae and renal membranes was examined in an effort to determine whether CT and CGRP interact with the same bone cell binding site, and to see whether the binding pattern was similar for bone and renal cortex. Specific binding of 125I-salmon CT to rat calvariae was inhibited by unlabeled salmon, porcine, or human CT, but not by rat CGRP. Binding of 125I-rat CGRP to calvariae was inhibited by CGRP and high doses of salmon CT, but not by human or porcine CT. Binding of 125I-salmon CT to renal membranes was inhibited by unlabeled salmon CT or rat CGRP, but no specific binding of 125I-rat CGRP could be detected. The results suggest that separate bone cell receptors for CT and CGRP exist and that CGRP can interact with renal receptors for CT.
为了确定降钙素(CT)和降钙素基因相关肽(CGRP)是否与相同的骨细胞结合位点相互作用,并观察骨和肾皮质的结合模式是否相似,研究了CT和CGRP与大鼠半侧颅骨及肾膜的结合情况。125I-鲑鱼降钙素与大鼠颅骨的特异性结合受到未标记的鲑鱼、猪或人降钙素的抑制,但不受大鼠CGRP的抑制。125I-大鼠CGRP与颅骨的结合受到CGRP和高剂量鲑鱼降钙素的抑制,但不受人或猪降钙素的抑制。125I-鲑鱼降钙素与肾膜的结合受到未标记的鲑鱼降钙素或大鼠CGRP的抑制,但未检测到125I-大鼠CGRP的特异性结合。结果表明,CT和CGRP存在各自独立的骨细胞受体,且CGRP可与肾中CT的受体相互作用。